|
Market Cap (4-Jun) $4,960,185 (1,007th) |
Close (30-Jun) $0.038 |
Volume (30-Jun) 1,963,571 |
Shortsold (11-May) 1 (0.00%) (717th) |
|
52w High $0.60 |
52w Low $0.083 |
P/E - |
EPS -0.84 |
CHM released this announcement to the ASX on 14 January 2022, 17:46. The announcement is not marked as price sensitive, and is 5 page(s) in length and 240.67kb in size.
You can view all announcements from CHM and see how they appear on a price chart on the announcements page.
At the date of this announcement, CHM was 0.433% short sold according to ASIC data. It was ranked the 299th most shorted stock on the ASX. It remains ranked 717th as of the latest reported data (11 May 2026).
| Other Recent Announcements from CHM | |
|---|---|
| Notice under section 708A | 29 June 2023, 15:34 |
| Application for quotation of securities - CHM | 29 June 2023, 15:29 |
| Results of Extraordinary General Meeting | 29 June 2023, 11:42 |
| Response to Appendix 3Y Query | 14 January 2022, 17:46 |
| Successful completion of 2nd dose cohort in CLTX CAR T trial | 17 December 2021, 9:43 |
| Change of Director's Interest Notice - JC, CE & GM | 14 December 2021, 17:25 |
| Key management changes for 2022 | 13 December 2021, 11:12 |
You must be logged in to post a reply.
Chimeric Therapeutics Ltd 